Objective: Systemic juvenile idiopathic arthritis (sJIA) is a chronic inflammatory disease characterized by systemic features and arthritis. Macrophage activation syndrome (MAS) is a severe complication of sJIA often involving the liver. MAS confined predominantly to the liver, causing severe hepatitis, has been increasingly recognized. When liver MAS is the primary manifestation, significant hepatic injury can occur; therefore, differentiation from other forms of sJIA-related liver involvement, which may warrant distinct treatment approaches, is required. This study examined liver pathology in patients with sJIA-MAS and explored potential mechanisms. Methods: This retrospective case series analyzed data from 4 patients with sJIA-MAS who presented with liver dysfunction and underwent core liver biopsies at Cincinnati Children’s Hospital Medical Center (2019-2024). Results: Four patients (age range 4-15 years) had elevated transaminases, with 1 meeting MAS criteria and 3 diagnosed with subclinical MAS. Liver biopsies showed portal and sinusoidal inflammatory infiltrates of CD3+ CD8+ T cells and CD163+ macrophages, with extensive hepatocellular damage, including centrilobular parenchymal collapse, multifocal necrosis, and lymphocyte-mediated bile duct injury. One case revealed features of venoocclusive disease, a novel finding. Elevated serum chemokine (C-X-C motif) ligand 9 (CXCL9) and rapid response to emapalumab (anti–interferon γ [anti–IFN-γ]) in all patients suggested IFN-γ–driven liver pathology. Conclusion: This study underscores the critical roles of CD8+ T cells, macrophages, and IFN-γ in sJIA-MAS hepatitis. Future research should explore whether serum biomarkers of IFN-γ activity can differentiate sJIA-MAS from other liver pathologies, such as drug-induced liver injury (methotrexate- or anakinra-induced) and hepatic steatosis, to guide tailored therapies.
24 June 2025 in International Journal of Pioneering Technology and Engineering
Early diagnosis and precise detection of skin cancer represent a global health priority since this disease remains highly dangerous while being among the most frequent ones. This research investigates the effectiveness of deep learning techniques, specifically Convolutional Neural Networks (CNN) and the VGG16 architecture, for skin cancer detection and classification. The study works with images from the International Skin Imaging Collaboration (ISIC) while employing resizing and augmentation preprocessing to boost its model performance. We evaluate the proposed model using precision, recall, and F1-score metrics to ensure accurate classification. The proposed CNN model achieved 87% validation accuracy, outperforming the VGG16 model, which attained 65% accuracy. Experimental results highlight the potential of AI-driven models in improving diagnostic accuracy, demonstrating their significance in medical image analysis and early skin cancer detection.
Identify pathways and candidate biomarkers that distinguish various liver pathologies in systemic juvenile idiopathic arthritis (SJIA) with the focus on li
Mpox, previously known as monkeypox, is an evolving zoonotic infection that raises serious public health issues, especially in low‐income settings. The recent outbreaks have indicated the existence of a need for fast, accurate and scalable diagnostics. The article under review examines how up to date convolutional neural networks may be combined with clinical knowledge in the process of early detection of mpox based on pictures of skin lesions. Among the architectures evaluated, MobileNetV2, VGG16 and GoogLeNet reported accuracy exceeding 95% in experiments conducted on publicly available datasets. While these findings demonstrate technical feasibility, such performance does not constitute evidence of clinical readiness. The reported performance reflects controlled offline validation and may be influenced by sample size, limited demographic diversity, and absence of standardized external evaluation. Future work involves building heterogeneous, labeled data sets and the integration of multi‐modal data for higher diagnostic consistency. Although deep learning‐based systems show promising experimental accuracy and computational efficiency, their integration into clinical workflows requires prospective validation, multi‐center evaluation, and regulatory assessment before real‐world deployment can be recommended.